This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a High Throughput Sequencing System. The contract has a ceiling value of $289,365.00 and was awarded on September 12, 2016, with a final completion date of October 28, 2016. The contract does not have a set-aside designation. Illumina, Inc. is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has received prior federal contract awards from agencies such as the NIH, CDC, USDA, and VA to provide sequencing systems, reagents, and services. This contract appears to be for the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, and support services, to support genomic sequencing and analysis requirements at NIAID.